Nephros (NEPH) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.72% |
| Dec 31, 2025 | 15.79% |
| Sep 30, 2025 | 18.46% |
| Jun 30, 2025 | 16.47% |
| Mar 31, 2025 | 20.19% |
| Dec 31, 2024 | 34.63% |
| Sep 30, 2024 | 17.57% |
| Jun 30, 2024 | 21.05% |
| Mar 31, 2024 | 34.00% |
| Dec 31, 2023 | 0.30% |
| Sep 30, 2023 | 20.30% |
| Jun 30, 2023 | 8.69% |
| Mar 31, 2023 | 26.53% |
| Dec 31, 2022 | -20.66% |
| Sep 30, 2022 | -37.92% |
| Jun 30, 2022 | -7.66% |
| Mar 31, 2022 | -23.67% |
| Dec 31, 2021 | -2.05% |
| Sep 30, 2021 | -2.58% |
| Jun 30, 2021 | -6.16% |
| Mar 31, 2021 | 8.47% |
| Dec 31, 2020 | 4.09% |
| Sep 30, 2020 | -11.74% |
| Jun 30, 2020 | 1.81% |
| Mar 31, 2020 | -45.49% |
| Dec 31, 2019 | 35.03% |
| Sep 30, 2019 | -17.85% |
| Jun 30, 2019 | 29.32% |
| Mar 31, 2019 | 17.41% |
| Dec 31, 2018 | -16.97% |
| Sep 30, 2018 | 25.14% |
| Jun 30, 2018 | 11.82% |
| Mar 31, 2018 | -24.10% |
| Dec 31, 2017 | 18.01% |
| Sep 30, 2017 | 5.82% |
| Jun 30, 2017 | -0.83% |
| Mar 31, 2017 | -4.07% |
| Dec 31, 2016 | 34.11% |
| Sep 30, 2016 | -11.32% |
| Jun 30, 2016 | -6.76% |
| Mar 31, 2016 | -3.41% |
| Dec 31, 2015 | -16.88% |
| Sep 30, 2015 | -9.15% |
| Jun 30, 2015 | -37.82% |